Gavin K. Magnuson

发表

Discovery and characterization of 2-aminobenzimidazole derivatives as selective NOD1 inhibitors.

R. Spreafico, John Calvin Reed, Brock T Brown, 2011, Chemistry and Biology.

Identification of Inhibitors of NOD1-Induced Nuclear Factor-κB Activation

John Calvin Reed, Brock T Brown, G. Roth, 2011, ACS medicinal chemistry letters.

Table 4, Probe and Analog Submissions to MLSMR (BioFocus DPI) for Gli-Sufu Antagonist ML340

Santhi Ganji, Ian Pass, Robert Ardecky, 2014 .

Small-molecule antagonists of Gli function

Tram A. Ngo, Jennifer K. T. Casabar, T. Chung, 2014 .

Cell-Based High-Throughput Luciferase Reporter Gene Assays for Identifying and Profiling Chemical Modulators of Endoplasmic Reticulum Signaling Protein, IRE1

Tram A. Ngo, John Calvin Reed, N. Cosford, 2015, Journal of biomolecular screening.

Capzimin is a potent and specific inhibitor of proteasome isopeptidase Rpn11.

Seth M. Cohen, T. Chung, R. Deshaies, 2017, Nature chemical biology.

Benzodiazepinone Derivatives Protect against Endoplasmic Reticulum Stress-Mediated Cell Death in Human Neuronal Cell Lines

D. Sheffler, John Calvin Reed, N. Cosford, 2014, ACS chemical neuroscience.

PPARδ repression in Huntington’s disease and its essential role in CNS translate into a potent agonist therapy

Gene W. Yeo, C. Ross, E. Masliah, 2016 .

PPARδ repression in Huntington’s disease and its essential role in CNS translate into a potent agonist therapy

Gene W. Yeo, C. Ross, E. Masliah, 2015, Nature Medicine.

Discovery and characterization of 2-aminobenzimidazole derivatives as selective NOD1 inhibitors.

R. Spreafico, John Calvin Reed, Brock T Brown, 2011, Chemistry & biology.

High Throughput Screening Assays for NOD1 Inhibitors - Probe 2

John Calvin Reed, T. Chung, Brock T Brown, 2010 .